- Home
- OSCR vs KRYS Comparison
OSCR vs KRYS Comparison
Compare OSCR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | KRYS |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | 2305 | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.8B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OSCR | KRYS |
|---|---|---|
| Price | $24.56 | $301.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $16.88 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 7.7M | 251.3K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | ★ 2.07 | 1.83 |
| Revenue | ★ $11,701,427,000.00 | $389,130,000.00 |
| Revenue This Year | $63.89 | $38.74 |
| Revenue Next Year | $5.30 | $32.53 |
| P/E Ratio | ★ $11.40 | $168.33 |
| Revenue Growth | 27.50 | ★ 33.94 |
| 52 Week Low | $10.69 | $127.99 |
| 52 Week High | $25.58 | $319.48 |
Technical Indicators
Market Signals| Indicator | OSCR | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 53.25 |
| Support Level | $12.01 | $253.89 |
| Resistance Level | $25.58 | $317.53 |
| Average True Range (ATR) | 1.45 | 11.04 |
| MACD | -0.22 | -1.54 |
| Stochastic Oscillator | 73.77 | 52.21 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.